Restructuring proposal adopted by creditors
globenewswire.com
news
2022-05-30 00:00:00

Orphazyme A/S in restructuring Company announcement                                                                No. 28/2022                                                                                                            Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, May 30, 2022 – Orphazyme A/S in restructuring (ORPHA.CO; ORPH) ('Orphazyme' or the 'Company'), a late-stage biopharmaceutical company, announces that today an in-court meeting was held where the restructuring proposal as published by the Company through company announcement no.
